Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.
about
Host immunity to Cryptococcus neoformansCarbohydrate-mimetic peptides for pan anti-tumor responsesA peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in miceToward a better understanding of the basis of the molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5a.Development of peptide mimics of a protective epitope of Vibrio cholerae Ogawa O-antigen and investigation of the structural basis of peptide mimicry.Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected UgandansSelf-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis.Characterization of gene use and efficacy of mouse monoclonal antibodies to Streptococcus pneumoniae serotype 8.Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantationFilamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.Advances in combating fungal diseases: vaccines on the thresholdProtective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection.Immunological evidence for functional rather than structural mimicry by a Shigella flexneri Y polysaccharide-mimetic peptideTherapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannanInduction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.The capsule of the fungal pathogen Cryptococcus neoformans.Masking the Pathogen: Evolutionary Strategies of Fungi and Their Bacterial Counterparts.
P2860
Q26823438-EF2F004F-A732-47D9-9421-0CC5AB9D7F88Q27023624-2A43BADD-018E-4301-92BD-E075579972D4Q27649541-1E26B7B9-2112-45DF-BB66-98D93C414E48Q31137207-8B957081-F2FD-4482-BACC-BA02EC4428B2Q33226009-10157425-4D9A-42F6-81AD-7D53E638D3BEQ33299645-943717E2-11B3-4699-8F7C-962AAD987F70Q33687443-11D0D285-180D-4DAF-8750-BFB436B8BBA9Q34033132-9BFF93AB-1D03-4DA6-8DB4-22768AB6C5E1Q34072411-BDD5AA8F-7C56-44F5-A48D-2CCE6BD6F98FQ34259665-91D59AC4-8026-444B-9922-F8B466F2DF95Q34484101-289FA790-6614-4548-B55D-C8A3A4D76F5DQ34720443-D554DCC5-C376-464C-AAC3-848E6C163AC6Q35987717-2C61EDBC-F72A-49A7-A0B3-1BA110F2E078Q36406460-5F6ACC1E-476A-413A-A86E-E8825A8E68DAQ36446429-00D3EC68-377E-496D-A7F6-EFDBF1743087Q36456615-0243E9B0-FCC4-46E4-8DA7-D56910FA50F5Q36746947-70DF7494-CBF9-4708-9448-6327316592F5Q36844895-65126D22-1897-49A9-9CFC-7942A82348E1Q37123421-6BA5F272-3EE7-4AB8-8243-B81F119C821BQ37337879-F2C2EA2D-DFD4-4BAF-92E8-39F620A4C2DFQ49410181-FB00048D-6CAA-4AC2-BBE0-FF6EBB9165B0
P2860
Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Immunogenicity and efficacy of ...... mmunoglobulin transgenic mice.
@ast
Immunogenicity and efficacy of ...... mmunoglobulin transgenic mice.
@en
type
label
Immunogenicity and efficacy of ...... mmunoglobulin transgenic mice.
@ast
Immunogenicity and efficacy of ...... mmunoglobulin transgenic mice.
@en
prefLabel
Immunogenicity and efficacy of ...... mmunoglobulin transgenic mice.
@ast
Immunogenicity and efficacy of ...... mmunoglobulin transgenic mice.
@en
P2093
P2860
P1476
Immunogenicity and efficacy of ...... immunoglobulin transgenic mice
@en
P2093
Andrew Lees
Robert W Maitta
Shelley Sims Belouski
P2860
P304
P356
10.1128/IAI.72.1.196-208.2004
P407
P577
2004-01-01T00:00:00Z